Abstract
Background Small for gestational age (SGA) birth is associated with poor long-term health outcomes. It is unclear whether maternal antihypertensive medication increases risk of SGA independently of maternal hypertension. Methods We analyzed associations between maternal hypertension and antihypertensive medication use and SGA among non-malformed singleton controls in the National Birth Defects Prevention Study. We defined SGA as birthweight < 10th percentile for a given gestational age, sex, race/ethnicity, and parity. We included 1045 SGA and 10,019 non-SGA births. We used logistic regression to calculate adjusted odds ratios (AORs) and 95% confidence intervals (CIs). We assessed interaction between hypertension, antihypertensive use, and maternal race/ethnicity and age. Results Overall, 122 (11.7%) SGA and 892 (8.9%) non-SGA mothers reported hypertension and 21 (2.0%) SGA and 154 (1.5%) non-SGA mothers reported antihypertensive use. The most commonly reported medications were centrally-acting antiadrenergics, β-blockers, calcium channel blockers, and diuretics. Compared to normotensive pregnancies, maternal hypertension, regardless of treatment (AOR, 1.49 [95% CI, 1.20, 1.86]), and untreated maternal hypertension [AOR, 1.46 (95% CI, 1.15, 1.86)] were associated with SGA. We observed a positive, but not significant, association between antihypertensive use and SGA. SGA risk varied by maternal race/ethnicity, being highest among Hispanic mothers, and age, being highest among mothers ≥ 35 years, but statistical tests for interaction were not significant. Conclusions Consistent with the literature, our findings suggest that maternal hypertension slightly increases SGA risk. We did not observe an appreciably increased SGA risk associated with antihypertensive medication use beyond that of the underlying maternal hypertension.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abalos, E., Duley, L., & Steyn, D. W. (2014). Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews (Online), 2, CD002252. https://doi.org/10.1002/14651858.CD002252.pub3.
Ananth, C. V., Peedicayil, A., & Savitz, D. A. (1995). Effect of hypertensive diseases in pregnancy on birthweight, gestational duration, and small-for-gestational-age births. Epidemiology (Cambridge, Mass.), 6(4), 391–395.
Andrade, S. E., Raebel, M. A., Brown, J., Lane, K., Livingston, J., Boudreau, D., … Platt, R. (2008). Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiology and Drug Safety, 17(3), 240–247. https://doi.org/10.1002/pds.1550.
Bateman, B. T., Bansil, P., Hernandez-Diaz, S., Mhyre, J. M., Callaghan, W. M., & Kuklina, E. V. (2012). Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. American Journal of Obstetrics and Gynecology, 206(2), 134.e131-138. https://doi.org/10.1016/j.ajog.2011.10.878.
Bateman, B. T., Hernandez-Diaz, S., Huybrechts, K. F., Palmsten, K., Mogun, H., Ecker, J. L., & Fischer, M. A. (2012). Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population. Hypertension, 60(4), 913–920. https://doi.org/10.1161/hypertensionaha.112.197095.
Catov, J. M., Nohr, E. A., Olsen, J., & Ness, R. B. (2008). Chronic hypertension related to risk for preterm and term small for gestational age births. Obstetrics and Gynecology, 112(2 Pt 1), 290–296. https://doi.org/10.1097/AOG.0b013e31817f589b.
Dietz, P., Bombard, J., Mulready-Ward, C., Gauthier, J., Sackoff, J., Brozicevic, P., … Taylor, A. (2014). Validation of self-reported maternal and infant health indicators in the Pregnancy Risk Assessment Monitoring System. Maternal and Child Health Journal, 18(10), 2489–2498. doi:https://doi.org/10.1007/s10995-014-1487-y.
Easterling, T. R. (2014). Pharmacological management of hypertension in pregnancy. Seminars in Perinatology, 38(8), 487–495. https://doi.org/10.1053/j.semperi.2014.08.016.
Hameed, A., Karaalp, I. S., Tummala, P. P., Wani, O. R., Canetti, M., Akhter, M. W., … Elkayam, U. (2001). The effect of valvular heart disease on maternal and fetal outcome of pregnancy. Journal of the American College of Cardiology, 37(3), 893–899.
Hosmer, D. W., & Lemeshow, S. (1992). Confidence interval estimation of interaction. Epidemiology (Cambridge, Mass.), 3(5), 452–456.
Jain, L., Ferre, C., & Vidyasagar, D. (1998). Racial differences in outcome of pregnancies complicated by hypertension. Journal of Maternal-Fetal Medicine, 7(1), 23–27. https://doi.org/10.1002/(SICI)1520-6661(199801/02)7:1<23::AID-MFM6>3.0.CO;2-T
Khedun, S. M., Maharaj, B., & Moodley, J. (2000). Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing? Paediatric Drugs, 2(6), 419–436.
Lapolla, A., Dalfra, M. G., & Fedele, D. (2008). Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Research and Clinical Practice, 80(1), 2–7. https://doi.org/10.1016/j.diabres.2007.11.009.
Lin, H. W., Phan, K., & Lin, S. J. (2006). Trends in off-label beta-blocker use: a secondary data analysis. Clinical Therapeutics, 28(10), 1736–1746. https://doi.org/10.1016/j.clinthera.2006.10.015. (Discussion 1710–1731).
Lydakis, C., Lip, G. Y., Beevers, M., & Beevers, D. G. (1999). Atenolol and fetal growth in pregnancies complicated by hypertension. American Journal of Hypertension, 12(6), 541–547.
Magee, L. A., Singer, J., & von Dadelszen, P. (2015). Less-tight versus tight control of hypertension in pregnancy. The New England Journal of Medicine, 372(24), 2367–2368. https://doi.org/10.1056/NEJMc1503870.
Martin, J. A., Hamilton, B. E., Osterman, M. J., Curtin, S. C., & Matthews, T. J. (2015). Births: Final data for 2013. National Vital Statistics Reports, 64(1), 1–65.
McCormick, M. C. (1985). The contribution of low birth weight to infant mortality and childhood morbidity. The New England Journal of Medicine, 312(2), 82–90. https://doi.org/10.1056/nejm198501103120204.
McCowan, L., & Horgan, R. P. (2009). Risk factors for small for gestational age infants. Best Practice and Research: Clinical Obstetrics and Gynaecology, 23(6), 779–793. https://doi.org/10.1016/j.bpobgyn.2009.06.003.
McCowan, L. M., Buist, R. G., North, R. A., & Gamble, G. (1996). Perinatal morbidity in chronic hypertension. British Journal of Obstetrics and Gynaecology, 103(2), 123–129.
Meidahl Petersen, K., Jimenez-Solem, E., Andersen, J. T., Petersen, M., Brodbaek, K., Kober, L., … Poulsen, H. E. (2012). beta-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2012-001185.
Miranda, M. L., Swamy, G. K., Edwards, S., Maxson, P., Gelfand, A., & James, S. (2010). Disparities in maternal hypertension and pregnancy outcomes: evidence from North Carolina, 1994–2003. Public Health Reports (Washington, D. C.: 1974), 125(4), 579–587.
Nakhai-Pour, H. R., Rey, E., & Berard, A. (2010). Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Research Part B, 89(2), 147–154. https://doi.org/10.1002/bdrb.20238.
Oken, E., & Gillman, M. W. (2003). Fetal origins of obesity. Obesity Research, 11(4), 496–506. https://doi.org/10.1038/oby.2003.69.
Orbach, H., Matok, I., Gorodischer, R., Sheiner, E., Daniel, S., Wiznitzer, A., … Levy, A. (2013). Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. American Journal of Obstetrics and Gynecology, 208(4), e301–306. https://doi.org/10.1016/j.ajog.2012.11.011. 301 .
Overpeck, M. D., Hediger, M. L., Zhang, J., Trumble, A. C., & Klebanoff, M. A. (1999). Birth weight for gestational age of Mexican American infants born in the United States. Obstetrics and Gynecology, 93(6), 943–947.
Reefhuis, J., Gilboa, S. M., Anderka, M., Browne, M. L., Feldkamp, M. L., & Hobbs, C. A. … National Birth Defects Prevention, Study. (2015). The National Birth Defects Prevention Study: A review of the methods. Birth Defects Research Part A, 103(8), 656–669. https://doi.org/10.1002/bdra.23384.
Rey, E., & Couturier, A. (1994). The prognosis of pregnancy in women with chronic hypertension. American Journal of Obstetrics and Gynecology, 171(2), 410–416.
Roberts, C. L., Ford, J. B., Algert, C. S., Antonsen, S., Chalmers, J., Cnattingius, S., … Weir, C. J. (2011). Population-based trends in pregnancy hypertension and pre-eclampsia: An international comparative study. BMJ Open, 1(1), e000101. https://doi.org/10.1136/bmjopen-2011-000101.
Sibai, B. M., Lindheimer, M., Hauth, J., Caritis, S., VanDorsten, P., Klebanoff, M., … Dombrowski, M. (1998). Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. The New England Journal of Medicine, 339(10), 667–671. https://doi.org/10.1056/nejm199809033391004.
Su, C. Y., Lin, H. C., Cheng, H. C., Yen, A. M., Chen, Y. H., & Kao, S. (2013). Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: A population-based study. PLoS ONE, 8(2), e53844. https://doi.org/10.1371/journal.pone.0053844.
van Gelder, M. M., van Rooij, I. A., de Walle, H. E., Roeleveld, N., & Bakker, M. K. (2013). Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: A validation study in the Netherlands. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 36(1), 43–54. https://doi.org/10.1007/s40264-012-0004-8.
von Dadelszen, P., Ornstein, M. P., Bull, S. B., Logan, A. G., Koren, G., & Magee, L. A. (2000). Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis. Lancet, 355(9198), 87–92.
Wallis, A. B., Saftlas, A. F., Hsia, J., & Atrash, H. K. (2008). Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. American Journal of Hypertension: Journal of the American Society of Hypertension, 21(5), 521–526. https://doi.org/10.1038/ajh.2008.20.
Xie, R. H., Guo, Y., Krewski, D., Mattison, D., Walker, M. C., Nerenberg, K., & Wen, S. W. (2014). Beta-blockers increase the risk of being born small for gestational age or of being institutionalised during infancy. Bjog, 121(9), 1090–1096. https://doi.org/10.1111/1471-0528.12678.
Zhang, J., & Bowes, W. A. Jr. (1995). Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstetrics and Gynecology, 86(2), 200–208.
Acknowledgements
We thank the participating families, scientists, and staff from all of the NBDPS sites. Drug information in the NBDPS is coded using the Slone Epidemiology Center Drug Dictionary, under license from the Slone Epidemiology Center at Boston University. This study was supported by a cooperative agreement from the Centers for Disease Control and Prevention (Cooperative Agreement U01DD001032). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This study was presented, in part, as a poster at the 28th Annual Meeting of the Society for Pediatric and Perinatal Epidemiologic Research (SPER) in Denver, Colorado, USA, June 15–16, 2015. We thank Cristian Pantea for replicating the analyses.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fisher, S.C., Van Zutphen, A.R., Romitti, P.A. et al. Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997–2011. Matern Child Health J 22, 237–246 (2018). https://doi.org/10.1007/s10995-017-2395-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-017-2395-8